longbridge

天辰生物-B

01779
----

全部股東

股東類型

  • 機構投資者27.61%
  • 個人與內幕人士27.40%
  • 公眾及其他19.55%
  • 創投/私募16.68%
  • 其他8.75%

主要股東

主要股東 最新
股東
Shanghai Tongrui Investment Management Co., Ltd.
16.68%1,273.42 萬0.00%+0
Nai-Chau SunCo-Founder & Executive Director
16.33%1,246.69 萬0.00%+0
Heng LiuCo-Founder, CEO, GM & Executive Chairman
11.07%844.77 萬0.00%+0
LongBio Pharma (Suzhou) Co., Ltd., ESOP
6.42%489.94 萬0.00%+0
Huzhou Yongshi Equity Investment Management Co., Ltd.
4.96%378.86 萬--+378.86 萬
Oriental Fortune (Wuhu) Equity Investment Fund Management Enterprise (L.P.)
4.03%307.75 萬--+307.75 萬
HighLight Capital
3.13%239.07 萬--+239.07 萬
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
3.02%230.55 萬--+230.55 萬
Shanghai Shifeng Xinhui Venture Capital Management Co., Ltd.
2.02%153.87 萬--+153.87 萬
Shenzhen Oriental Fortune Venture Capital Management Co., Ltd.
1.53%117.14 萬--+117.14 萬
Shanghai Lingang Lanwan Private Equity Fund Management Co., Ltd.
1.37%104.59 萬--+104.59 萬
Changshu Southeast Asian Industry Investment Co., Ltd.
1.34%102.58 萬--+102.58 萬
Shanxi Securities Co., Ltd.
1.25%95.43 萬--+95.43 萬
Bozhou Jian'an Investment Fund Management Co., Ltd.
1.08%82.07 萬--+82.07 萬
Hangzhou Beijia Investment Management Co., Ltd.
0.98%74.71 萬--+74.71 萬
Shanghai Sanyi Asset Management Co., Ltd.
0.95%72.77 萬--+72.77 萬
PharMab, Inc
0.90%68.32 萬0.00%+0
Hefei Hongta Industrial Investment Partnership (Limited Partnership)
0.77%58.57 萬--+58.57 萬
Shenzhen Xinsheng Huachuang Enterprise Management Partnership (Limited Partnership)
0.67%51.29 萬--+51.29 萬
Shenzhen Sangel Venture Capital Co., Ltd.
0.67%51.29 萬--+51.29 萬
© 2026 Longbridge｜服務條款隱私政策